Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas J. Schall currently holds 33,350 shares of ChemoCentryx, Inc. (CCXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas J. Schall has been a net seller of CCXI stock. They have purchased $108.4K and sold $57.7M worth of shares.
Thomas J. Schall's most recent insider trade was on Jun 11, 2026, when they sold 33,350 shares at $0.00 per share.
Thomas J. Schall serves as Executive at ChemoCentryx, Inc. (CCXI). They have executed 180 insider transactions totaling $57.8M over their tenure at the company.
Thomas J. Schall holds the position of Executive at ChemoCentryx, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Thomas J. Schall has shown a selling trading pattern, with $108.4K in total purchases and $57.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas J. Schall was on Aug 4, 2022, when they sold $6.5M worth of CCXI shares. This transaction involved 130,000 shares at $50.24 per share.
Thomas J. Schall currently owns 33,350 shares of ChemoCentryx, Inc. (CCXI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas J. Schall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas J. Schall has 180 Form 4 filings on record as an insider at ChemoCentryx, Inc..
Set alerts for Thomas J. Schall and 40,000+ other insiders.